0001801385-22-000005.txt : 20220301 0001801385-22-000005.hdr.sgml : 20220301 20220301212529 ACCESSION NUMBER: 0001801385-22-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220226 FILED AS OF DATE: 20220301 DATE AS OF CHANGE: 20220301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Romano Kathryn CENTRAL INDEX KEY: 0001801385 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38210 FILM NUMBER: 22701036 MAIL ADDRESS: STREET 1: C/O KRYSTAL BIOTECH, INC. STREET 2: 2100 WHARTON STREET, SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Krystal Biotech, Inc. CENTRAL INDEX KEY: 0001711279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 821080209 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 BUSINESS PHONE: (412) 586-5830 MAIL ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 4 1 wf-form4_164618791185342.xml FORM 4 X0306 4 2022-02-26 0 0001711279 Krystal Biotech, Inc. KRYS 0001801385 Romano Kathryn C/O KRYSTAL BIOTECH, INC. 2100 WHARTON STREET, SUITE 701 PITTSBURGH PA 15203 0 1 0 0 Chief Accounting Officer Common Stock 2022-02-26 4 F 0 1472 62.50 D 18128 D Stock Option (Right to Buy) 63.55 2022-02-28 4 A 0 50000 0 A 2032-02-28 Common Stock 50000.0 50000 D Represents tax withholding upon the vesting of 4,900 shares of restricted stock on February 26, 2022. The closing price on February 25, 2022 of the Company's common stock on NASDAQ. The option vests in four equal annual installments beginning on February 28, 2023. /s/ Kathryn Romano 2022-03-01